Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.72 EUR | +1.60% | -0.38% | -29.88% |
10:10am | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Business Summary
Number of employees: 224
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
FYB203
65.4
%
| - | - | 28 | 65.4 % | - |
FYB201
28.5
%
| - | - | 12 | 28.5 % | - |
FYB202
6.1
%
| - | - | 3 | 6.1 % | - |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 37 | 100.0 % | 42 | 100.0 % | +14.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 16-09-30 |
Enno Spillner
DFI | Director of Finance/CFO | 55 | 23-03-31 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Sabrina Müller
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | 53 | 22-05-31 | |
Meike Heger
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Olaf Stiller
FOU | Founder | 47 | 06-12-31 |
Peter Wendeln
BRD | Director/Board Member | 59 | - |
Klaus Röhrig
BRD | Director/Board Member | 47 | 20-12-09 |
Wolfgang Essler
BRD | Director/Board Member | - | 23-07-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,656,902 | 7,446,341 ( 42.17 %) | 0 | 42.17 % |
Company contact information
Formycon AG
Fraunhoferstraße 15 Martinsried, Planegg
82152, Munich
+49 89 864 667 100
http://formycon.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.88% | 738M | |
+0.67% | 43.84B | |
+4.14% | 41.68B | |
+45.26% | 41.25B | |
-10.92% | 27.04B | |
+7.36% | 25.53B | |
-25.67% | 18.18B | |
-4.23% | 12.29B | |
+25.34% | 12.29B | |
+6.93% | 11.15B |
- Stock Market
- Equities
- FYB Stock
- Company Formycon AG